Kinesiotaping Along with Mulligan's Mobilization with Movement in Adhesive Capsulitis
Effectiveness of Kinesiotaping Along with Mulligan's Mobilization with Movement on Improving Pain and Function in Patients with Adhesive Capsulitis of Shoulder: a Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kerala
-
Calicut, Kerala, India
- Awh special college
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Primary adhesive capsulitis,
- Controlled diabetes mellitus,
- Restriction of movements in capsular pattern,
- Shoulder pain for more than one month.
Exclusion Criteria:
- Secondary adhesive capsulitis,
- Cancer,
- Bilateral adhesive capsulitis,
- Skin infections in the shoulder region,
- Shoulder joint infections,
- Wounds or ulcers in the shoulder region,
- Hypersensitivity to tape,
- Recent shoulder dislocation,
- Recent shoulder fractures.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Experimental Group
The experimental group received Kinesiotaping, Mulligan's mobilization with movement, and conventional physiotherapy.
|
Kinesio taping is a therapeutic technique that involves applying a special elastic tape to the skin to support and stabilize muscles and joints without restricting their range of motion.
Mulligan's mobilization with movement (MWM) techniques involve the application of a sustained manual force or glide to a joint while the patient actively performs a movement that is typically painful or restricted.
Mulligan Mobilization with Movement, Ultrasound Therapy, Active assisted ROM exercises for shoulder, Capsular Stretching exercises
|
|
Active Comparator: Control Group
Control group received only Mulligan's mobilization with movement and conventional physiotherapy
|
Mulligan's mobilization with movement (MWM) techniques involve the application of a sustained manual force or glide to a joint while the patient actively performs a movement that is typically painful or restricted.
Mulligan Mobilization with Movement, Ultrasound Therapy, Active assisted ROM exercises for shoulder, Capsular Stretching exercises
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analogue Scale
Time Frame: From enrollment to the end of treatment at 4 weeks
|
The Visual Analog Scale (VAS) is a tool for measuring subjective experiences, like pain.
It's typically a 10 cm line, with endpoints marking the extremes (e.g., "no pain" to "worst imaginable pain").
The minimum value is 0, and the maximum is 10.
Respondents mark a point on the line that corresponds to their experience.
Higher scores usually indicate worse outcomes for negative experiences like pain.
|
From enrollment to the end of treatment at 4 weeks
|
|
Range of motion
Time Frame: From enrollment to the end of treatment at 4 weeks
|
Range of motion (ROM) measures the movement extent of a joint or body part, expressed in degrees.
Minimum values indicate restricted movement (e.g., 0° signifies no movement), while maximum values represent full movement capacity (e.g., 180° for shoulder flexion).
Higher scores generally indicate a better outcome, as they reflect greater flexibility and joint function.
|
From enrollment to the end of treatment at 4 weeks
|
|
Shoulder Pain and Disability Index
Time Frame: From enrollment to the end of treatment at 4 weeks
|
The Shoulder Pain and Disability Index (SPADI) is a 13-item questionnaire assessing pain and disability due to shoulder issues.
Scores range from 0 to 100, with 0 indicating no pain/disability and 100 indicating severe pain/disability.
Higher scores signify worse outcomes, reflecting greater pain and functional impairment.
|
From enrollment to the end of treatment at 4 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Masood Khan, MPTh, King Saud University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- AWH/EC/03/2021/3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.